There is no publicly documented direct business partnership, investment, board relationship, or personal connection between Vas Narasimhan and John Collison as of September 2026. The clearest connection is indirect: Narasimhan joined the board of AI company Anthropic in 2026, while Anthropic uses Stripe, the financial technology company co-founded by Collison, for important parts of its payments and billing infrastructure.
That distinction matters. Searches for Vas Narasimhan and John Collison can make it seem as though the two executives have worked together directly, but the available evidence instead points to an overlapping technology ecosystem involving Novartis, Anthropic, Stripe, artificial intelligence, healthcare, and digital infrastructure.
Who Is Vas Narasimhan?
Vasant “Vas” Narasimhan is an American physician and business executive who has served as chief executive officer of Novartis since 2018. He joined the Swiss pharmaceutical company in 2005 and held a series of senior positions in vaccines, pharmaceuticals and drug development before becoming CEO.
Narasimhan holds a bachelor’s degree in biological sciences from the University of Chicago, an M.D. from Harvard Medical School and a master’s degree in public policy from Harvard’s John F. Kennedy School of Government. His career has combined medicine, public health, pharmaceutical development and corporate leadership.
Under his leadership, Novartis has increasingly concentrated on innovative medicines and technologies such as radioligand therapies, small interfering RNA, and cell and gene therapies. Novartis says Narasimhan has been involved during his career in the development and approval of more than 35 novel medicines and vaccines.
Novartis’ current biography states that the company has more than 77,000 employees, operates in approximately 120 countries and reached more than 300 million patients with its medicines in 2025.
Narasimhan’s Move Into AI Governance
A significant development came on April 14, 2026, when Anthropic’s Long-Term Benefit Trust appointed Narasimhan to the AI company’s board of directors.
Anthropic said his experience bringing medicines through highly regulated development processes was particularly relevant as increasingly powerful AI systems move into healthcare, science and other high-impact fields. Narasimhan described AI as capable of accelerating areas such as understanding disease biology, identifying potential drug targets and designing medicines.
The appointment is more than a side role unrelated to his pharmaceutical career. Anthropic has been expanding its presence in life sciences. Reuters reported in September 2026 that the company had established a biology laboratory in the San Francisco Bay Area as part of broader work involving AI, biological research and drug development.
This makes Narasimhan one of the more prominent bridges between the global pharmaceutical sector and frontier AI governance.
Who Is John Collison?
John Collison is the co-founder and president of Stripe, the financial technology company he created with his older brother Patrick Collison in 2010. Stripe’s current leadership information continues to list Patrick as co-founder and CEO and John as co-founder and president.
Collison grew up in Ireland and began building websites while still a teenager. He later studied physics at Harvard University before leaving to work on Stripe full time. According to Stanford University’s Technology Ventures Program, the brothers created Stripe to make accepting payments over the internet easier for businesses.
Stripe has since grown far beyond basic card processing. Its products now cover areas including payments, billing, invoicing, tax, fraud prevention, financial data and infrastructure for internet businesses.
The scale is substantial. Stripe reported in February 2026 that businesses using its platform generated $1.9 trillion in total volume during 2025, up 34% from the previous year. The company also said its programmable financial services supported more than five million businesses directly or through platforms.
A 2026 tender offer valued Stripe at approximately $159 billion, although that is a valuation of the privately held company, not John Collison’s personal net worth. Individual ownership stakes are not fully disclosed publicly, so company valuation should not be treated as a direct measurement of either brother’s wealth.
Are Vas Narasimhan and John Collison Directly Connected?
Based on publicly available corporate announcements, leadership records and major news coverage reviewed through September 2026, there is no verified direct relationship between Vas Narasimhan and John Collison.
No reliable evidence currently shows that:
- Collison serves on a Novartis board or executive body
- Narasimhan holds a role at Stripe
- they founded or invested in a company together
- Novartis and Stripe announced a partnership involving the two personally
- either executive reports to or formally advises the other
- they have publicly disclosed a personal or family relationship
Their established professional positions remain separate. Narasimhan leads Novartis and sits on Anthropic’s board, while Collison is president and co-founder of Stripe.
The important connection lies one step away.
Also Read: Ed Sheeran and Al Pacino
The Anthropic Link Between Vas Narasimhan and John Collison
Anthropic creates the Claude family of AI models. In 2026, Narasimhan became one of its directors. Separately, Anthropic is a significant Stripe customer, creating an indirect link between the business environments of Narasimhan and Collison.
Stripe’s official Anthropic customer study says Anthropic uses multiple Stripe services, including:
| Area | Stripe infrastructure used by Anthropic |
|---|---|
| Payments | Stripe Payments |
| Subscriptions | Stripe Billing |
| Enterprise billing | Stripe Invoicing |
| Checkout | Stripe Elements and Link |
| Fraud management | Stripe Radar |
| Financial reporting | Stripe Data Pipeline |
| Complex usage billing | Metronome |
Stripe says Anthropic began using its infrastructure even before Claude’s public launch in 2023. Anthropic originally used Stripe for enterprise billing and later expanded the relationship as Claude introduced consumer subscriptions and grew internationally.
Anthropic co-founder and president Daniela Amodei has said publicly that the company relies on Stripe to help scale its business while allowing Anthropic to concentrate on product development and its customers.
That relationship does not, however, demonstrate that Narasimhan personally works with John Collison. Corporate partnerships often involve large teams, and neither Stripe nor Anthropic has publicly identified Collison and Narasimhan as participants in a joint project.
Why Anthropic Creates an Interesting Strategic Overlap
The indirect connection becomes more meaningful when viewed through the direction of all three organizations.
Novartis: AI Applied to Medicine
Narasimhan has pushed Novartis toward greater use of data science and digital technologies in drug research and organizational operations. Novartis describes technology leadership in research and development as a central element of its strategy.
Anthropic: AI Moving Into Science and Healthcare
Anthropic appointed Narasimhan specifically as it was placing greater emphasis on AI applications involving healthcare and life sciences. Its April 2026 announcement highlighted his pharmaceutical development and global health experience.
By September, Reuters reported that Anthropic had expanded this work into physical biological experimentation through a laboratory in the Bay Area.
Stripe: Infrastructure for the AI Economy
Stripe has positioned itself as financial infrastructure for rapidly growing AI businesses.
Its 2025 annual letter said Stripe’s programmable financial services support leading AI companies and highlighted the increasingly global nature of AI businesses. Stripe reported that businesses on its platform generated $1.9 trillion in volume during 2025.
Stripe’s relationship with Anthropic is especially concrete because Stripe provides the payment and subscription systems used to monetize Claude.
The result is a three-part ecosystem:
Narasimhan and Novartis bring pharmaceutical and healthcare expertise → Anthropic develops advanced AI → Stripe provides financial infrastructure supporting Anthropic’s commercial growth.
That is a legitimate institutional overlap, but it should not be misrepresented as a direct Narasimhan-Collison partnership.
How Their Careers Differ
Although both executives operate around rapidly advancing technology, their backgrounds are fundamentally different.
| Category | Vas Narasimhan | John Collison |
|---|---|---|
| Main organization | Novartis | Stripe |
| Current primary role | CEO | Co-founder and President |
| Core industry | Pharmaceuticals and biotechnology | Financial technology |
| Background | Medicine, public health, drug development | Software, entrepreneurship, payments |
| Major AI connection | Anthropic board member | Stripe serves major AI companies including Anthropic |
| Education | University of Chicago, Harvard Medical School, Harvard Kennedy School | Studied physics at Harvard before leaving to build Stripe |
| Company leadership start | Novartis CEO since 2018 | Stripe co-founder since 2010 |
Narasimhan’s career has centered on developing medicines within scientific and regulatory systems. Collison’s has centered on building technological infrastructure that allows internet companies to accept payments, manage revenue and operate internationally.
Their industries increasingly intersect because pharmaceutical research, AI and cloud-based financial infrastructure are becoming more technologically interconnected.
Could Novartis, Anthropic and Stripe Become More Closely Connected?
There is a credible reason to watch the overlap, but speculation should be separated from established facts.
Anthropic is moving deeper into life sciences, Narasimhan now sits on its board, and Stripe already supplies Anthropic with important commercial infrastructure. Those facts could create more opportunities for interaction across healthcare, AI and financial technology.
What cannot currently be claimed is that Narasimhan and Collison themselves are developing a product, investment, partnership or strategy together. No authoritative public announcement reviewed for this article confirms such an arrangement.
What Is the Most Accurate Way to Describe Their Connection?
The most accurate description is:
Vas Narasimhan and John Collison are prominent executives in different industries with an indirect institutional connection through Anthropic and Stripe. Narasimhan serves on Anthropic’s board, while Collison co-founded and leads Stripe, whose technology powers parts of Anthropic’s billing and payments operations.
Calling them business partners, colleagues or co-investors would go beyond the available evidence.
FAQ
Are Vas Narasimhan and John Collison business partners?
No direct business partnership between Vas Narasimhan and John Collison has been publicly documented as of September 2026. Their identifiable connection is indirect through Anthropic’s relationship with Stripe.
How is Vas Narasimhan connected to Anthropic?
Anthropic’s Long-Term Benefit Trust appointed Narasimhan to the company’s board on April 14, 2026. Anthropic cited his experience in medicine, pharmaceutical development, regulated industries and global health as particularly relevant to the company’s future work.
How is John Collison connected to Anthropic?
John Collison is co-founder and president of Stripe. Anthropic uses Stripe products for payments, subscriptions, invoicing, fraud prevention and financial operations, although there is no evidence that Collison personally manages the Anthropic account.
Does Stripe work with Anthropic?
Yes. Stripe has published a detailed customer case study documenting Anthropic’s use of Stripe Payments, Billing, Invoicing, Link, Radar, Data Pipeline and other infrastructure.
Does Vas Narasimhan work for Anthropic?
Narasimhan remains CEO of Novartis. He separately serves as a member of Anthropic’s board of directors, a role he took on in April 2026.
Why are Vas Narasimhan and John Collison relevant to the AI industry?
Narasimhan brings healthcare, pharmaceutical development and regulatory expertise to Anthropic’s board. Collison leads Stripe, which provides financial infrastructure to Anthropic and numerous other technology and AI companies. Their relevance therefore comes from different sides of the expanding AI economy.
Also Read: Florence Pugh and Al Pacino
